Towards Healthcare
Lateral Flow Assays Market Reaches USD 12.76 Billion in 2025

Lateral Flow Assays Market 2025 Growth Across Infectious Disease, Cardiac Testing, and Food Safety Applications

According to market projections, the global lateral flow assays market, valued at USD 11.45 billion in 2024, is anticipated to reach USD 33.58 billion by 2034, growing at a CAGR of 7.94% over the next decade. The lateral flow assays market is expanding due to growing demand for point-of-care testing as well as growing development of multiplex and eco-friendly LFAs. North America led the market due to the presence of established OTC channels. 

Content

  • Insight Code: 5993
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The lateral flow assays market in 2025 is valued at USD 12.76 billion and is projected to climb to USD 33.58 billion by 2034, with a CAGR of 7.94% over the forecast period.

North America is currently leading the lateral flow assays market due to the growing LFA adoption rates.

The lateral flow assays market includes six segments, such as by product type, by technique, by application, by sample type, by end user, and by region.

Some key players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, and QuidelOrtho Corporation.

The lateral flow assays are rapid, point-of-care diagnostic devices that detect target analytes in a sample, which may be blood, urine, saliva, or swab.

Gov. UK, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions